# OnCo record john-haanen (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/john-haanen/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "john-haanen" ;
  schema:name "John Haanen"@en ;
  schema:description "John Haanen led the first randomised phase 3 trial of TIL therapy, which beat ipilimumab in melanoma."@en ;
  schema:url <https://onco.cc/people/john-haanen/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Haanen%20JB%5BAuthor%5D%20tumor-infiltrating%20lymphocytes> ;
  schema:jobTitle "Medical Oncologist, Netherlands Cancer Institute; Professor, Leiden University Medical Center" ;
  schema:sameAs <https://orcid.org/0000-0001-5884-7704> ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:technologies <https://onco.cc/technologies/til-therapy/> ;
  onco:drugs <https://onco.cc/drugs/lifileucel/>, <https://onco.cc/drugs/ipilimumab/> ;
  onco:institutions <https://onco.cc/institutions/nki/> ;
  schema:affiliation <https://onco.cc/institutions/nki/> .